These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 16711548)
21. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin. Penido C; Castro-Faria-Neto HC; Vieira-de-Abreu A; Figueiredo RT; Pelled A; Martins MA; Jose PJ; Williams TJ; Bozza PT Am J Respir Cell Mol Biol; 2001 Dec; 25(6):707-16. PubMed ID: 11726396 [TBL] [Abstract][Full Text] [Related]
22. [Eosinophil chemoattractants and related factors in nasal polyps]. Saigusa H; Miyazawa T; Suzuki M; Iino Y; Kodera K Nihon Jibiinkoka Gakkai Kaiho; 2006 Nov; 109(11):774-80. PubMed ID: 17165591 [TBL] [Abstract][Full Text] [Related]
23. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Ying S; Robinson DS; Meng Q; Rottman J; Kennedy R; Ringler DJ; Mackay CR; Daugherty BL; Springer MS; Durham SR; Williams TJ; Kay AB Eur J Immunol; 1997 Dec; 27(12):3507-16. PubMed ID: 9464841 [TBL] [Abstract][Full Text] [Related]
24. Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart. Diny NL; Hou X; Barin JG; Chen G; Talor MV; Schaub J; Russell SD; Klingel K; Rose NR; Čiháková D Eur J Immunol; 2016 Dec; 46(12):2749-2760. PubMed ID: 27621211 [TBL] [Abstract][Full Text] [Related]
25. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils. Shin SH; Park JY; Jeon CH; Choi JK; Lee SH Laryngoscope; 2000 Aug; 110(8):1353-7. PubMed ID: 10942140 [TBL] [Abstract][Full Text] [Related]
26. The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts. Puxeddu I; Bader R; Piliponsky AM; Reich R; Levi-Schaffer F; Berkman N J Allergy Clin Immunol; 2006 Jan; 117(1):103-10. PubMed ID: 16387592 [TBL] [Abstract][Full Text] [Related]
27. Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells. Komiya A; Nagase H; Yamada H; Sekiya T; Yamaguchi M; Sano Y; Hanai N; Furuya A; Ohta K; Matsushima K; Yoshie O; Yamamoto K; Hirai K Cell Immunol; 2003 Oct; 225(2):91-100. PubMed ID: 14698143 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical localization of eotaxin immunoreactivity in nasal polyps. Seto H; Suzaki H; Shioda S Acta Otolaryngol Suppl; 2004 Aug; (553):99-104. PubMed ID: 15277046 [TBL] [Abstract][Full Text] [Related]
30. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo. Sabroe I; Conroy DM; Gerard NP; Li Y; Collins PD; Post TW; Jose PJ; Williams TJ; Gerard CJ; Ponath PD J Immunol; 1998 Dec; 161(11):6139-47. PubMed ID: 9834099 [TBL] [Abstract][Full Text] [Related]
31. A novel, selective, and orally available antagonist for CC chemokine receptor 3. Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911 [TBL] [Abstract][Full Text] [Related]
32. Eotaxin synthesis by nasal polyp fibroblasts. Nonaka M; Pawankar R; Saji F; Yagi T Acta Otolaryngol; 1999; 119(7):816-20. PubMed ID: 10687940 [TBL] [Abstract][Full Text] [Related]
33. An emerging role for eotaxins in neurodegenerative disease. Huber AK; Giles DA; Segal BM; Irani DN Clin Immunol; 2018 Apr; 189():29-33. PubMed ID: 27664933 [TBL] [Abstract][Full Text] [Related]
34. Interleukin (IL)-4 and to a lesser extent either IL-13 or interferon-gamma regulate the production of eotaxin-2/CCL24 in nasal polyps. Lezcano-Meza D; Dávila-Dávila B; Vega-Miranda A; Negrete-García MC; Teran LM Allergy; 2003 Oct; 58(10):1011-7. PubMed ID: 14510718 [TBL] [Abstract][Full Text] [Related]
35. [Role of eotaxin in the pathophysiology of asthma]. Paplińska M; Grubek-Jaworska H; Chazan R Pneumonol Alergol Pol; 2007; 75(2):180-5. PubMed ID: 17973226 [TBL] [Abstract][Full Text] [Related]
36. Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues. Rothenberg ME Am J Respir Cell Mol Biol; 1999 Sep; 21(3):291-5. PubMed ID: 10460744 [No Abstract] [Full Text] [Related]
37. The kinetics of allergen-induced eotaxin level in nasal lavage fluid: its key role in eosinophil recruitment in nasal mucosa. Terada N; Hamano N; Kim WJ; Hirai K; Nakajima T; Yamada H; Kawasaki H; Yamashita T; Kishi H; Nomura T; Numata T; Yoshie O; Konno A Am J Respir Crit Care Med; 2001 Aug; 164(4):575-9. PubMed ID: 11520718 [TBL] [Abstract][Full Text] [Related]
38. The CC chemokine receptor antagonist met-RANTES inhibits eosinophil effector functions. Elsner J; Petering H; Kimmig D; Wells TN; Proudfoot AE; Kapp A Int Arch Allergy Immunol; 1999; 118(2-4):462-5. PubMed ID: 10224475 [TBL] [Abstract][Full Text] [Related]
39. Nasal fluid release of eotaxin-3 and eotaxin-2 in persistent sinonasal eosinophilic inflammation. De Corso E; Baroni S; Battista M; Romanello M; Penitente R; Di Nardo W; Passali GC; Sergi B; Fetoni AR; Bussu F; Zuppi C; Paludetti G Int Forum Allergy Rhinol; 2014 Aug; 4(8):617-24. PubMed ID: 24989688 [TBL] [Abstract][Full Text] [Related]
40. CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implication in eosinophil recruitment. Tillie-Leblond I; Hammad H; Desurmont S; Pugin J; Wallaert B; Tonnel AB; Gosset P Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):586-92. PubMed ID: 10934091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]